Ergotamine use in severe diabetic autonomic neuropathy.

BACKGROUND: Symptomatic postural hypotension in diabetes is uncommon. When it does occur, it can prove debilitating and difficult to treat. We report here the therapeutic challenges encountered in managing a patient with severe postural hypotension secondary to diabetes-related autonomic neuropathy....

Full description

Bibliographic Details
Main Authors: Toh, V, Duncan, E, Lewis, N, Fichter, L, Matthews, DR
Format: Journal article
Language:English
Published: 2006
_version_ 1826264447388221440
author Toh, V
Duncan, E
Lewis, N
Fichter, L
Matthews, DR
author_facet Toh, V
Duncan, E
Lewis, N
Fichter, L
Matthews, DR
author_sort Toh, V
collection OXFORD
description BACKGROUND: Symptomatic postural hypotension in diabetes is uncommon. When it does occur, it can prove debilitating and difficult to treat. We report here the therapeutic challenges encountered in managing a patient with severe postural hypotension secondary to diabetes-related autonomic neuropathy. CASE REPORT: A 69-year-old gentleman with a 23-year history of Type 1 diabetes mellitus and multiple microvascular complications was admitted with symptoms of severe postural hypotension. Cardiovascular autonomic testing confirmed the presence of severe autonomic neuropathy. He failed to respond to non-pharmacological measures, fludrocortisone, midodrine, octreotide, erythropoietin and increased caffeine intake. Eventually he was commenced on half a Cafergot suppository (giving him a dose of ergotamine 1 mg and caffeine 50 mg) which resulted in dramatic clinical improvement. CONCLUSION: Ergotamine may be considered in refractory cases of postural hypotension.
first_indexed 2024-03-06T20:07:57Z
format Journal article
id oxford-uuid:298b2048-6aaf-478f-a4cd-c85f58f6828d
institution University of Oxford
language English
last_indexed 2024-03-06T20:07:57Z
publishDate 2006
record_format dspace
spelling oxford-uuid:298b2048-6aaf-478f-a4cd-c85f58f6828d2022-03-26T12:19:49ZErgotamine use in severe diabetic autonomic neuropathy.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:298b2048-6aaf-478f-a4cd-c85f58f6828dEnglishSymplectic Elements at Oxford2006Toh, VDuncan, ELewis, NFichter, LMatthews, DRBACKGROUND: Symptomatic postural hypotension in diabetes is uncommon. When it does occur, it can prove debilitating and difficult to treat. We report here the therapeutic challenges encountered in managing a patient with severe postural hypotension secondary to diabetes-related autonomic neuropathy. CASE REPORT: A 69-year-old gentleman with a 23-year history of Type 1 diabetes mellitus and multiple microvascular complications was admitted with symptoms of severe postural hypotension. Cardiovascular autonomic testing confirmed the presence of severe autonomic neuropathy. He failed to respond to non-pharmacological measures, fludrocortisone, midodrine, octreotide, erythropoietin and increased caffeine intake. Eventually he was commenced on half a Cafergot suppository (giving him a dose of ergotamine 1 mg and caffeine 50 mg) which resulted in dramatic clinical improvement. CONCLUSION: Ergotamine may be considered in refractory cases of postural hypotension.
spellingShingle Toh, V
Duncan, E
Lewis, N
Fichter, L
Matthews, DR
Ergotamine use in severe diabetic autonomic neuropathy.
title Ergotamine use in severe diabetic autonomic neuropathy.
title_full Ergotamine use in severe diabetic autonomic neuropathy.
title_fullStr Ergotamine use in severe diabetic autonomic neuropathy.
title_full_unstemmed Ergotamine use in severe diabetic autonomic neuropathy.
title_short Ergotamine use in severe diabetic autonomic neuropathy.
title_sort ergotamine use in severe diabetic autonomic neuropathy
work_keys_str_mv AT tohv ergotamineuseinseverediabeticautonomicneuropathy
AT duncane ergotamineuseinseverediabeticautonomicneuropathy
AT lewisn ergotamineuseinseverediabeticautonomicneuropathy
AT fichterl ergotamineuseinseverediabeticautonomicneuropathy
AT matthewsdr ergotamineuseinseverediabeticautonomicneuropathy